SCHEMBL18530486

SCHEMBL18530486

CN(C(=O)O)c1ccc(-c2ccc(-c3ccc(C(=O)N4CCC(F)(F)CC4)cc3)cc2-c2cccc(Cl)c2)o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A7 Q99884 6/20 0.42
▸ SLC6A3 Q01959 1/20 0.42
▸ HPGD P15428 4/20 0.40
▸ MGLL Q99685 1/20 0.40
▸ FASN P49327 2/20 0.37
▸ USP2 O75604 5/20 0.37
▸ CYP1A2 P05177 5/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ CYP3A4 P08684 4/20 0.37
▸ SMN1; SMN2 Q16637 4/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ CYP2C9 P11712 3/20 0.37
▸ CYP2C19 P33261 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ HBB P68871 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ CHRM2 P08172 1/20 0.36
▸ CHRM3 P20309 1/20 0.36
▸ TSHR P16473 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18530503 0.87 PAK4 (0.41) SLC6A7FASNALDH1A1SMN1; SMN2MAPK1
SCHEMBL18530601 0.83 SLC6A7 (0.43) SLC6A7SLC6A3HPGDMGLLFASN
SCHEMBL21143154 0.82 SLC6A7 (0.41) SLC6A7SLC6A3HPGDMGLLFASN
SCHEMBL18530622 0.81 FASN (0.38) MGLLFASNALDH1A1CYP3A4SMN1; SMN2
SCHEMBL18542118 0.78 L3MBTL1 (0.38) SLC6A7SLC6A3HPGDMGLLHTR1A
SCHEMBL18530527 0.77 SLC6A7 (0.52) SLC6A7SLC6A3HPGDMGLLFASN
SCHEMBL18530639 0.77 SLC6A7 (0.52) SLC6A7SLC6A3HPGDMGLLFASN
SCHEMBL18530652 0.77 PAK4 (0.38) HPGDFASNSMN1; SMN2HTTHTR1A
SCHEMBL18530546 0.77 HPGD (0.35) HPGDSMN1; SMN2KMT2ATSHRHTT
SCHEMBL16345438 0.76 PAK4 (0.42) HPGDFASNUSP2ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3337796-A1 3-(PYRIDIN-3-YL)-ACRYLAMIDE AND N-(PYRIDIN-3-YL)-ACRYLAMIDE DERIVATIVES AND THEIR USE AS PAK OR NAMPT MODULATORS Karyopharm Therapeutics, Inc. (US) 2018-06-27 — — EP disclosed
WO-2017031213-A1 3-(PYRIDIN-3-YL)-ACRYLAMIDE AND N-(PYRIDIN-3-YL)-ACRYLAMIDE DERIVATIVES AND THEIR USE AS PAK OR NAMPT MODULATORS Karyopharm Therapeutics Inc. (US) 2017-02-23 — — WO disclosed
Send feedback